ED Coding & Reimbursement Alert - 2016 Issue 7
Industry Note: CMS Creates Proposal for New Medication Injection Payments
Subscribe or sign in to view the full article.
Article Overview
This article explains a CMS proposal to test alternative Medicare Part B drug payment approaches for physician-administered medications and compares them with the current payment methodology. It also summarizes concerns raised by physician advocacy organizations about the pace and potential impact of the proposal. The piece is relevant to coders, reimbursement staff, practice administrators, and policy readers tracking Medicare drug payment changes and CMS model development.
Why This Topic Matters
Payment model changes for physician-administered drugs can affect reimbursement, beneficiary access, and practice operations. Readers following Medicare policy and drug payment methodology will want to understand the scope of the proposal and the stakeholder response.
What You Will Learn
- What CMS proposed regarding alternative Medicare Part B drug payment approaches
- How the proposal compares a study model with a control approach
- What concerns physician advocacy groups raised about the initiative
- Why the proposal matters for Medicare beneficiaries and physician practices
Who Should Read This
- Medical coders
- Reimbursement specialists
- Physician practice administrators
- Healthcare policy analysts
- Medicare compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com